Bristol-Myers Squibb Co. reported a smaller-than-expected decline in third-quarter revenue, despite lost sales as the result of the pharmaceutical company’s exit of a diabetes alliance earlier this year.
WSJ.com: US Business, Wall Street Journal: Business
Fri, 10/24/2014 - 5:22am
Bristol-Myers Squibb Co. reported a smaller-than-expected decline in third-quarter revenue, despite lost sales as the result of the pharmaceutical company’s exit of a diabetes alliance earlier this year.